Wednesday - December 6, 2023
Cancer Action Network: CMS Investigative Study to Examine Benefit of Multi-Cancer Early Detection Tests for Medicare Beneficiaries
November 21, 2023
WASHINGTON, Nov. 21 (TNSres) -- The American Cancer Society Cancer Action Network issued the following news release on Nov. 20, 2023:

Grail, LLC announced this morning that the Centers for Medicare and Medicaid Services (CMS) and Food and Drug Administration (FDA) approved an Investigational Device Exemption (IDE) study for the company's Galleri multi-cancer early detection (MCED) test to evaluate the technology's capacity to reduce late-stage cancer diagnoses for the large group of . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

What's your
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products